AU4228997A - Method for treating homozygous familial hypercholesterolemia - Google Patents

Method for treating homozygous familial hypercholesterolemia

Info

Publication number: AU4228997A
Authority: AU; Australia
Prior art keywords: familial hypercholesterolemia; homozygous familial; treating; treating homozygous; hypercholesterolemia
Prior art date: 1996-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU42289/97A

Inventor

Yale B Mitchel

Jonathan A. Tobert

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-09

Filing date

1997-07-03

Publication date

1998-02-02

1996-08-28 Priority claimed from GBGB9617898.3A external-priority patent/GB9617898D0/en

1997-07-03 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

1998-02-02 Publication of AU4228997A publication Critical patent/AU4228997A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU42289/97A 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia Abandoned AU4228997A (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US2142096P	1996-07-09	1996-07-09
US60021420		1996-07-09
GBGB9617898.3A GB9617898D0 (en)	1996-08-28	1996-08-28	Method for treating homozygous familial hypercholesterolemia
GB9617898		1996-08-28
US2935196P	1996-10-31	1996-10-31
US60029351		1996-10-31
PCT/US1997/011792 WO1998001100A2 (en)	1996-07-09	1997-07-03	Method for treating homozygous familial hypercholesterolemia

Publications (1)

Publication Number	Publication Date
AU4228997A true AU4228997A (en)	1998-02-02

Family

ID=27268450

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AU42289/97A Abandoned AU4228997A (en)	1996-07-09	1997-07-03	Method for treating homozygous familial hypercholesterolemia
AU36672/97A Abandoned AU3667297A (en)	1996-07-09	1997-07-03	Therapy for combined hyperlipidemia
AU43261/97A Abandoned AU4326197A (en)	1996-07-09	1997-07-03	Pharmaceutical compositions

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AU36672/97A Abandoned AU3667297A (en)	1996-07-09	1997-07-03	Therapy for combined hyperlipidemia
AU43261/97A Abandoned AU4326197A (en)	1996-07-09	1997-07-03	Pharmaceutical compositions

Country Status (2)

Country	Link
AU (3)	AU4228997A (en)
WO (3)	WO1998001116A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030212996A1 (en) *	1996-02-08	2003-11-13	Wolzien Thomas R.	System for interconnection of audio program data transmitted by radio to remote vehicle or individual with GPS location
SI1117392T1 (en) *	1998-09-30	2004-06-30	Warner-Lambert Company Llc	Method for preventing or delaying catheter-based revascularization
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
IL156445A0 (en)	2001-01-26	2004-01-04	Schering Corp	Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
ME00145B (en)	2001-01-26	2010-10-10	Merck Sharp & Dohme	The use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
WO2002079174A2 (en)	2001-03-28	2002-10-10	Schering Corporation	Enantioselective synthesis of azetidinone intermediate compounds
ES2272776T3 (en)	2001-09-21	2007-05-01	Schering Corporation	TREATMENT OF XANTOMAS WITH DERIVATIVES OF AZETIDINONE AS INHIBITORS OF STEROL ABSORPTION.
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
CN1620499A (en) *	2001-12-21	2005-05-25	哥本哈根大学医院	Gamete recruitment and developmental competence in mammals - by inhibiting de novo sterol biosynthesis and/or promoting sterol efflux
AR040588A1 (en)	2002-07-26	2005-04-13	Schering Corp	PHARMACEUTICAL FORMULATION INCLUDING AN INHIBITOR OF CHOLESTEROL ABSORPTION AND AN INHIBITOR OF A HMGCO TO REDUCTASE
WO2004043457A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
DE602004018617D1 (en)	2003-03-07	2009-02-05	Schering Corp	SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF HYPERCHOLESTEROLMIA
DE602004016123D1 (en)	2003-03-07	2008-10-09	Schering Corp	SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF HYPERCHOLESTEROLMIA
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7192944B2 (en)	2003-03-07	2007-03-20	Schering Corp.	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JOP20080381B1 (en)	2007-08-23	2023-03-28	Amgen Inc	Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9)
JOP20200043A1 (en)	2011-05-10	2017-06-16	Amgen Inc	Ways to treat or prevent cholesterol disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4806564A (en) *	1987-05-26	1989-02-21	Merck & Co., Inc.	Antihypercholesterolemic beta-lactones
US4997849A (en) *	1989-06-23	1991-03-05	Merck & Co., Inc.	Microbial transformation of simvastatin
US5393893A (en) *	1993-11-08	1995-02-28	Apotex, Inc.	Process for producing simvastatin and analogs thereof

1997
- 1997-07-03 WO PCT/US1997/012426 patent/WO1998001116A1/en not_active Ceased
- 1997-07-03 WO PCT/US1997/010867 patent/WO1998001119A2/en not_active Ceased
- 1997-07-03 AU AU42289/97A patent/AU4228997A/en not_active Abandoned
- 1997-07-03 WO PCT/US1997/011792 patent/WO1998001100A2/en not_active Ceased
- 1997-07-03 AU AU36672/97A patent/AU3667297A/en not_active Abandoned
- 1997-07-03 AU AU43261/97A patent/AU4326197A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1998001100A3 (en)	1998-02-12
WO1998001119A2 (en)	1998-01-15
AU4326197A (en)	1998-02-02
WO1998001100A2 (en)	1998-01-15
WO1998001116A1 (en)	1998-01-15
AU3667297A (en)	1998-02-02

Publication	Publication Date	Title
AU1527897A (en)	1997-08-20	Method for treating the prostate
AU3813397A (en)	1998-03-06	Apparatus for treating chondromalicia
AU2543097A (en)	1997-10-17	Method for treating pain
AU2587297A (en)	1997-10-17	Method for treating pain
AU2326297A (en)	1997-09-22	Method for treating liquid materials
AU9035498A (en)	1999-03-16	Method for treating pain
AU1915695A (en)	1995-08-29	Stormwater treatment system/apparatus
AU4228997A (en)	1998-02-02	Method for treating homozygous familial hypercholesterolemia
AU3829895A (en)	1996-05-06	Methods for treating resistant tumors
AU2808997A (en)	1997-11-26	Method for treating inflammation
AU5362598A (en)	1998-06-22	Method for improving wastewater treatment
AU2340897A (en)	1997-10-17	Method for treating pain
EP0722723A3 (en)	1997-11-26	Phenol derivatives for treating multiple sclerosis
AU4672597A (en)	1998-05-15	Method for treating urinary reflux
AU3704297A (en)	1998-04-14	Method
AU9034798A (en)	1999-03-16	Method for treating pain
AU2991497A (en)	1997-11-12	Method for odor reduction
AU3896597A (en)	1998-02-25	Method for treating substance abuse
AU5369498A (en)	1998-06-22	Compounds and methods for treating cancer
AU1547397A (en)	1997-08-20	Method for treating hazardous waste
AU4070897A (en)	1998-03-06	Method for treating diabetes
AU3740697A (en)	1998-02-25	Method for treating excessive aggression
GB9617898D0 (en)	1996-10-09	Method for treating homozygous familial hypercholesterolemia
AU4669097A (en)	1998-05-22	Oncostatin m for treating inflammation
AU5767598A (en)	1998-08-18	Method for preventing filters from blocking